EM2508B "Less is More: Studying Stem Cells to Improve Diagnosis and Therapy in Myeloid Malignancies" (IM GR-080125)

Purpose and Overview

The purpose of this lecture is to review the current standard-of-care for the myelodysplastic syndromes and acute myeloid leukemia, as well as the biology of the aberrant stem cells that underlies both of these diseases. Research into improving methods to predict relapse in the myelodysplastic syndromes will be reviewed, as well as future planned clinical trials using these methods. Research into understanding the mechanisms underlying high-risk disease in acute myeloid leukemia will be reviewed, including how these efforts are leading to new therapeutic strategies.

Target Audience

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Describe curative and non-curative therapies for the myelodysplastic syndromes and acute myeloid leukemia
  • Describe the role for bone marrow transplantation in the myelodysplastic syndromes and acute myeloid leukemia
  • Describe how the cell-of-origin influences response to therapy in acute myeloid leukemia
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
08/01/2025
Course expires: 
09/01/2025
Cost:
$0.00
Rating: 
0

Photo: First Last, M.D.
Stephen Chung, M.D.
Assistant Professor of Internal Medicine
Division of Hematology & Oncology

Available Credit

  • 1.00 AMA

Price

Cost:
$0.00
Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome